Hledání článků
Filtry
Kovesdy CP, Molnár MZ, Czira ME, et al. Diagnostic accuracy of serum parathyroid hormone levels in kidney transplant recipients with moderate‑to‑advanced CKD. Nephron Clin Pract 2011;118:c78–c85.
Felker GM, et al., NHLBI Heart Failure Clinical Research Network. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 2011;364:797–805.
Singh V, Dhungana SP, Singh B, Vijayverghia R, Nain CK, Sharma N, Bhalla A, Gupta PK. Midodrine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study. J Hepatol. 2011, doi:10.1016/j. jhep.2011.04.027
Chrysochou C, Foley RN, Young JF, et al. Dispelling the myth: the use of renin‑angiotensin blockade in atheromatous renovascular disease. Nephrol Dial Transplant. 2011 Oct 12. [Epub ahead of print]
Vaglio A, Palmisano A, Alberici F et al. Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open‑label randomised controlled trial. Lancet 2011;378:338–346.
Fukuda A, et al. Angiotensin II‑dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease. Kidney Int 2011. doi: 10.1038/ki.2011.306.
Harcourt BE, Sourris KC, Coughlan MT, et al. Targeted reduction of advance glycation improves renal function in obesity. Kidney Int 2011, 80:190–198.
Jouret F, et al. Positron‑emission computed tomography in cyst infection in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2011; 6:1644–1650.
Cejka D, Jager‑Lansky A, Kieweg H, et al. Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients. Nephrol Dial Transplant 2011 May 25. [Epub ahead of print]
Cejka D, Herberth J, Branscum AJ, et al. Sclerostin and Dickkopf‑1 in renal osteodystrophy. Clin J Am Soc Nephrol 2011;6:877–882.
Molnar MZ, Mehrotra R, Duong U, Kovesdy CP, Kalantar‑Zadeh K. Association of hemoglobin and survival in peritoneal dialysis patients. Clin J Am Soc Nephrol 2011;6:1973–1981.